RHABDOID TUMOR
Clinical trials for RHABDOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new RHABDOID TUMOR trials appear
Sign up with your email to follow new studies for RHABDOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could selinexor shrink tough childhood tumors?
Disease control Recruiting nowThis study tests a drug called selinexor in children and young adults whose Wilms tumor, rhabdoid tumor, or other solid tumors have come back or not responded to treatment. The goal is to see if the drug can shrink tumors. About 45 participants will take selinexor pills, and doct…
Matched conditions: RHABDOID TUMOR
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:27 UTC
-
New stem cell approach aims to boost immune attack on tough childhood cancers
Disease control Recruiting nowThis study tests a stem cell transplant that removes certain immune cells (alpha/beta T cells and CD19+ B cells) and adds a drug called zoledronic acid to help the donor cells fight solid tumors that have come back or not responded to treatment. It includes children and young adu…
Matched conditions: RHABDOID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New hope for rare childhood cancer: drug trial opens
Disease control Recruiting nowThis study tests a drug called ONO-4538 in 23 people aged 1 year and older with advanced or recurrent rhabdoid tumors that did not respond to or could not tolerate prior chemotherapy. The main goal is to see if the drug shrinks tumors. Researchers will also track survival and sid…
Matched conditions: RHABDOID TUMOR
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Engineered immune cells take on childhood cancers in new trial
Disease control Recruiting nowThis early-stage trial tests a personalized cell therapy for children and young adults (up to age 21) with solid tumors that have come back or not responded to standard treatment. Doctors take the patient's own immune cells, modify them to recognize a protein called B7-H3 on tumo…
Matched conditions: RHABDOID TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 19, 2026 11:59 UTC